Sponsor:
NeuroCognitive and Behavioral Institute Clinical Research Foundation
Code:
NCT06086015
Conditions
Anxiety Disorders
Eligibility Criteria
Sex: All
Age: 5+
Healthy Volunteers: Not accepted
Interventions
transcranial alternating current stimulation (tACS)
Brief summary:
Conditions
Anxiety Disorders
Study ID
NCT06086015
Start date
Jun 1, 2021
Status verified date
Oct, 2023
Completion date
Dec 31, 2024
Anticipated
Primary completion date
Jun 30, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 5+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: Active group
placebo comparator: Sham group
Interventions
transcranial alternating current stimulation (tACS)
Primary outcome measure
Central contacts
Locations
NCI Clinical Research Foundation
Recruiting
Mount Arlington, New Jersey, United States, 07856
Contacts
Sponsor
NeuroCognitive and Behavioral Institute Clinical Research Foundation
Last update posted
Oct 18, 2023
Last verified
Oct, 2023
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-23. This information was provided to ClinicalTrials.gov by NeuroCognitive and Behavioral Institute Clinical Research Foundation on 2023-10-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.